If your patients require assistance affording their PharmaEssentia medication, we're here to help. We have programs and referral services to help patients with all different types of insurance, or no insurance at all.
Eligible patients can receive BESREMi® (ropeginterferon alfa-2b-njft) for as little as $0 per month.* This program covers copay, coinsurance, or deductible expenses for those who qualify.
Patients may be eligible if they meet requirements, such as:
Visit BESREMiCopay.com to enroll
*Restrictions apply and are subject to change. Not available to patients with prescription insurance plans through any federal or state healthcare programs, including but not limited to Medicare, Medicaid, TRICARE, and Veterans Health Administration. This offer is not valid for cash-paying patients, where BESREMi is not covered by the patient's commercial insurance, or where the plan reimburses patients for the entire cost of BESREMi. See BESREMiCopay.com for full terms, conditions, and eligibility criteria.
For illustration purposes only.
PharmaEssentia SOURCE will work with your patients to identify potential sources of insurance coverage and organizations that may help with various treatment-related needs, including costs related to therapy.
If your patient is uninsured or has limited coverage, they may be eligible to receive their medication at no cost through this program.†;
Patients may be eligible if they meet requirements, such as:
†Restrictions apply and are subject to change.
Patients experiencing insurance delays or gaps in coverage may be eligible for a temporary supply of BESREMi.‡
‡Restrictions apply and are subject to change.
© 2026 PharmaEssentia Corporation. All rights reserved.
BESREMi, the BESREMi logo, and PharmaEssentia are registered trademarks of
PharmaEssentia Corporation, and BESREMi Pen, the BESREMi Pen logo, the PharmaEssentia logo,
PharmaEssentia SOURCE, and the PharmaEssentia SOURCE logo are trademarks of PharmaEssentia Corporation.
US-BSRM-2100061 (V11.0) 09/2026
800-700-5053
